C series
—
10.3.2025
(C/2025/1414)
Language of the case: English
Appellant: European Commission (represented by: S. Delaude, B. Rous Demiri, I. Galindo Martín and F. van Schaik, Agents)
Other party to the proceedings: Aloe Vera of Europe BV
The appellant claims that the Court should:
—set aside the judgment under appeal;
—make use of its power under the second sentence of the first paragraph of Article 61 of the Statute of the Court of Justice of the European Union to give final judgment in the matter by dismissing the Application;
—alternatively, refer the case back to the General Court for consideration of the pleas and arguments not already assessed; and
—order the Respondent to pay the costs, if it gives final judgment in the matter, or reserve the costs of the present proceedings, if it refers the case back to the General Court.
First, the Commission respectfully submits that the General Court erred in law in finding that Regulation (EC) No 1925/2006 (1) lays down two cumulative conditions to prohibit the addition to foods or the use in the manufacture of foods of certain substances and preparations/ingredients containing them and, thus in applying that legal test to decide on the validity of Regulation (EU) 2021/468 (2). In particular, the General Court erred in considering that it is not sufficient that the substance is found to be harmful to health by misinterpreting that Regulation.
Second, the Commission contends that the General Court erred in law in that it breached its duty to state reasons and overstepped its scrutiny powers in scientific matters as regards whether hydroxyanthracenic derivatives are harmful to health.
—
Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of vitamins and minerals and of certain other substances to foods (OJ 2006, L 404, p. 26).
—
Commission Regulation (EU) 2021/468 of 18 March 2021 amending Annex III to Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards botanical species containing hydroxyanthracene derivatives (OJ 2021, L 96, p. 6).
ELI: http://data.europa.eu/eli/C/2025/1414/oj
ISSN 1977-091X (electronic edition)
—